Literature DB >> 24667788

Analyses of the mitochondrial mutations in the Chinese patients with sporadic Creutzfeldt-Jakob disease.

Jin Zhang1, Zhi-Xia Zhang2, Peng-Chen Du3, Wei Zhou2, Su-Dong Wu4, Qi-Ling Wang5, Cao Chen2, Qi Shi2, Chen Chen3, Chen Gao2, Chan Tian2, Xiao-Ping Dong6.   

Abstract

Pathogenic mitochondrial DNA (mtDNA) mutations leading to mitochondrial dysfunction can cause a variety of chronic diseases in central nervous system (CNS). However, the role of mtDNA mutations in sporadic Creutzfeldt-Jakob disease (sCJD) has still been unknown. In this study, we comparatively analyzed complete mtDNA sequences of 31 Chinese sCJD patients and 32 controls. Using MITOMASTER and PhyloTree, we characterized 520 variants in sCJD patients and 507 variants in control by haplogroup and allele frequencies. We classified the mtDNAs into 40 sub-haplogroups of 5 haplogroups, most of them being Asian-specific haplogroups. Haplogroup U, an European-specific haplogroups mtDNA, was found only in sCJD. The analysis to control region (CR) revealed a 31% increase in the frequency of mtDNA CR mutations in sCJD versus controls. In functional elements of the mtDNA CR, six CR mutations were in conserved sequence blocks I (CSBI) in sCJD, while only one in control (P<0.05). More mutants in transfer ribonucleic acid-Leu (tRNA-Leu) were detected in sCJD. The frequencies of two synonymous amino-acid changes, m.11467A>G, p.(=) in NADH dehydrogenase subunit 4 (ND4) and m.12372G>A, p.(=) in NADH dehydrogenase subunit 5 (ND5), in sCJD patients were higher than that of controls. Our study, for the first time, screened the variations of mtDNA of Chinese sCJD patients and identified some potential disease-related mutations for further investigations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24667788      PMCID: PMC4266738          DOI: 10.1038/ejhg.2014.52

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  39 in total

Review 1.  Cooperation of a "reactive oxygen cycle" with the Q cycle and the proton cycle in the respiratory chain--superoxide generating and cycling mechanisms in mitochondria.

Authors:  S S Liu
Journal:  J Bioenerg Biomembr       Date:  1999-08       Impact factor: 2.945

2.  Effects of purifying and adaptive selection on regional variation in human mtDNA.

Authors:  Eduardo Ruiz-Pesini; Dan Mishmar; Martin Brandon; Vincent Procaccio; Douglas C Wallace
Journal:  Science       Date:  2004-01-09       Impact factor: 47.728

3.  Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases.

Authors:  R Egensperger; S Kösel; N M Schnopp; P Mehraein; M B Graeber
Journal:  Neuropathol Appl Neurobiol       Date:  1997-08       Impact factor: 8.090

4.  Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication.

Authors:  Pinar E Coskun; M Flint Beal; Douglas C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

5.  A novel protective prion protein variant that colocalizes with kuru exposure.

Authors:  Simon Mead; Jerome Whitfield; Mark Poulter; Paresh Shah; James Uphill; Tracy Campbell; Huda Al-Dujaily; Holger Hummerich; Jon Beck; Charles A Mein; Claudio Verzilli; John Whittaker; Michael P Alpers; John Collinge
Journal:  N Engl J Med       Date:  2009-11-19       Impact factor: 91.245

6.  Marked changes in mitochondrial DNA deletion levels in Alzheimer brains.

Authors:  M Corral-Debrinski; T Horton; M T Lott; J M Shoffner; A C McKee; M F Beal; B H Graham; D C Wallace
Journal:  Genomics       Date:  1994-09-15       Impact factor: 5.736

7.  Severe impairment of complex I-driven adenosine triphosphate synthesis in leber hereditary optic neuropathy cybrids.

Authors:  Alessandra Baracca; Giancarlo Solaini; Gianluca Sgarbi; Giorgio Lenaz; Agostino Baruzzi; Anthony H V Schapira; Andrea Martinuzzi; Valerio Carelli
Journal:  Arch Neurol       Date:  2005-05

8.  Genome wide association studies and prion disease.

Authors:  Ana Lukic; Simon Mead
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

9.  Leber's Hereditary Optic Neuropathy: The Mitochondrial Connection Revisited.

Authors:  Khaled K Abu-Amero
Journal:  Middle East Afr J Ophthalmol       Date:  2011-01

10.  Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study.

Authors:  Simon Mead; Mark Poulter; James Uphill; John Beck; Jerome Whitfield; Thomas E F Webb; Tracy Campbell; Gary Adamson; Pelagia Deriziotis; Sarah J Tabrizi; Holger Hummerich; Claudio Verzilli; Michael P Alpers; John C Whittaker; John Collinge
Journal:  Lancet Neurol       Date:  2009-01       Impact factor: 44.182

View more
  5 in total

1.  mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.

Authors:  Harrison E Grace; Patrick Galdun; Edward J Lesnefsky; Franklin D West; Shilpa Iyer
Journal:  Stem Cells Dev       Date:  2019-05-20       Impact factor: 3.272

2.  Identification of Somatic Mitochondrial DNA Mutations, Heteroplasmy, and Increased Levels of Catenanes in Tumor Specimens Obtained from Three Endometrial Cancer Patients.

Authors:  Matthew J Young; Ravi Sachidanandam; Dale B Hales; Laurent Brard; Kathy Robinson; Md Mostafijur Rahman; Pabitra Khadka; Kathleen Groesch; Carolyn K J Young
Journal:  Life (Basel)       Date:  2022-04-09

Review 3.  Contribution of Mitochondrial DNA Variation to Chronic Disease in East Asian Populations.

Authors:  Dayan Sun; Yang Wei; Hong-Xiang Zheng; Li Jin; Jiucun Wang
Journal:  Front Mol Biosci       Date:  2019-11-15

4.  Genomic analysis of mutations in platelet mitochondria in a case of benzene-induced leukaemia: A case report.

Authors:  Dianpeng Wang; Xiangli Yang; Diya Cai; Peimao Li; Zhimin Zhang; Dafeng Lin; Yanfang Zhang
Journal:  Medicine (Baltimore)       Date:  2021-01-08       Impact factor: 1.817

5.  Transcriptomic Determinants of Scrapie Prion Propagation in Cultured Ovine Microglia.

Authors:  Juan F Muñoz-Gutiérrez; Sebastián Aguilar Pierlé; David A Schneider; Timothy V Baszler; James B Stanton
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.